UMIN ID: UMIN000048497
Registered date:28/07/2022
Web-based Survey on the Occurrence of Emotional Blunting and Treatment Needs in Japanese Patients with Major Depressive Disorder
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Major Depressive Disorder |
| Date of first enrollment | 2022/07/29 |
| Target sample size | 3000 |
| Countries of recruitment | Japan |
| Study type | Observational |
| Intervention(s) |
Outcome(s)
| Primary Outcome | Occurrence ratio of Emotional Blunting (EB) in Japanese patients with major depressive disorder |
|---|---|
| Secondary Outcome | 1. The scores of Oxford Depression Questionnaire (ODQ) 2. Correlation between severity of EB (ODQ) and severity of depressive symptoms (PHQ-9: Patient Health Questionnaire-9), or anxiety symptoms (GAD-7: Generalized Anxiety Disorder-7), social functioning (WSAS: Work and Social Adjustment Scale), QOL (EQ-5D-5L) 3. Patient's perception for EB 4. Treatment need for EB |
Key inclusion & exclusion criteria
| Age minimum | 18years-old |
|---|---|
| Age maximum | 59years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | The preliminary web-based questionnaire ask whether any of the following conditions are met, and those who meet the conditions are not eligible for the survey. (1) Those who have been diagnosed with bipolar disorder. (2) Those who have been diagnosed and are under treatment for serious progressive physical illnesses such as cancer and heart failure. |
Related Information
| Primary Sponsor | Takeda Pharmaceutical Company Ltd. |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Takeda Pharmaceutical Company Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Tomoki Ohashi |
| Address | Shinagawa East One Tower 11F, 2-16-1 Konan, Minato-ku, Tokyo, Japan Japan 108-0075 |
| Telephone | 070-1399-0192 |
| to_ohhashi@macromillcarenet.jp | |
| Affiliation | Macromill Carenet, Inc. Macromill Carenet, Inc. |
| scientific contact | |
| Name | Keita Fujikawa |
| Address | 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo, Japan Japan |
| Telephone | 03-3278-2111 |
| keita.fujikawa@takeda.com | |
| Affiliation | Takeda Pharmaceutical Company Ltd. Japan Medical Office |